Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126990612 | 12699061 | 2 | F | 2015 | 20160920 | 20160830 | 20160923 | EXP | US-GLAXOSMITHKLINE-US2016GSK123287 | GLAXOSMITHKLINE | 0.00 | F | Y | 54.42000 | KG | 20160923 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126990612 | 12699061 | 1 | PS | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Y | UNKNOWN | 20658 | ||||||||||
126990612 | 12699061 | 2 | SS | SINEMET | CARBIDOPALEVODOPA | 1 | U | UNKNOWN | 0 | ||||||||||
126990612 | 12699061 | 3 | SS | NUPLAZID | PIMAVANSERIN TARTRATE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126990612 | 12699061 | 1 | Product used for unknown indication |
126990612 | 12699061 | 2 | Parkinson's disease |
126990612 | 12699061 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126990612 | 12699061 | OT |
126990612 | 12699061 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126990612 | 12699061 | Condition aggravated | |
126990612 | 12699061 | Depressed level of consciousness | |
126990612 | 12699061 | Fatigue | |
126990612 | 12699061 | Hypotension | |
126990612 | 12699061 | Miosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |